Personalised human albumin in patients with cirrhosis and ascites: design and rationale for the ALB-TRIAL - a randomised clinical biomarker validation trial.
- DOI
- 10.1136/bmjopen-2023-079309
- Published
- 2024 Feb 14
- Container
- BMJ open
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1136/bmjopen-2023-079309,
title = {Personalised human albumin in patients with cirrhosis and ascites: design and rationale for the ALB-TRIAL - a randomised clinical biomarker validation trial.},
author = {Torp N and Israelsen M and Coenraad M and Papp M and Shawcross D and Korenjak M and Angeli P and Laleman W and Juanola A and Gines P and Trebicka J and Krag A and MICROB-PREDICT Consortium},
year = {2024},
journal = {BMJ open},
doi = {10.1136/bmjopen-2023-079309},
url = {https://doi.org/10.1136/bmjopen-2023-079309}
}RIS
TY - JOUR TI - Personalised human albumin in patients with cirrhosis and ascites: design and rationale for the ALB-TRIAL - a randomised clinical biomarker validation trial. AU - Torp N AU - Israelsen M AU - Coenraad M AU - Papp M AU - Shawcross D AU - Korenjak M AU - Angeli P AU - Laleman W AU - Juanola A AU - Gines P AU - Trebicka J AU - Krag A AU - MICROB-PREDICT Consortium PY - 2024 JO - BMJ open DO - 10.1136/bmjopen-2023-079309 UR - https://doi.org/10.1136/bmjopen-2023-079309 ER -
APA
N, T., M, I., M, C., M, P., D, S., M, K., P, A., W, L., A, J., P, G., J, T., A, K., & Consortium, M. (2024). Personalised human albumin in patients with cirrhosis and ascites: design and rationale for the ALB-TRIAL - a randomised clinical biomarker validation trial.. BMJ open. https://doi.org/10.1136/bmjopen-2023-079309
Source records
- pubmed · retrieved 2026-09-25T20:58:26.083Z